Egyphar

Egyphar, founded in 1998, is a pharmaceutical company focused on developing and marketing prescribed pharmaceutical products. Operating within the Healthcare and Pharmaceuticals sectors, it aims to deliver innovative, affordable healthcare solutions that improve patient quality of life. The company's mission centers on addressing critical patient needs through dedicated research and development, ensuring alignment with the latest scientific advancements for continuous innovation.

The company offers a diverse product range across therapeutic areas such as cardiology, hypertension, orthopedics, internal medicine, psychiatry, gynecology, vitamins, pediatrics, and supportive care. Employing 500 - 1,000 individuals, Egyphar manages its operations and market presence effectively. Meet Egyphar's team to learn about the expertise driving their commitment to healthcare excellence and patient well-being. Its primary operational hub is located in Cairo, Egypt.

As a progressive B2B entity, Egyphar seeks leadership by addressing unmet patient needs and integrating scientific discoveries into its product pipeline. Their focus on prescribed pharmaceuticals highlights a commitment to evidence-based medicine and therapeutic efficacy. With revenue of $120.9M, the company demonstrates significant market penetration and operational scale. By prioritizing innovation and affordability, Egyphar aims to positively impact public health and patient outcomes.